Advanced humidity algorithm
The myAirvo 2 algorithm’s intelligent controls deliver Optimal Humidity to patients at 37, 34 or 31 °C.
Discover the myAirvo 2 technology
Learn how myAirvo™ 2 can help patients manage chronic respiratory conditions
Humidified high flow therapy has been shown to ease symptoms such as frequent coughs and breathlessness as well as reduce escalation of care in patients with conditions such as COPD.1-4 The myAirvo 2 is an innovative humidified high flow system that delivers the therapy through an Optiflow™ nasal cannula and a trio of advanced technologies.
Humidified high flow therapy has been shown to ease symptoms such as frequent coughs and breathlessness as well as reduce escalation of care in patients with conditions such as COPD.1-4 The myAirvo 2 is an innovative humidified high flow system that delivers the therapy through an Optiflow™ nasal cannula and a trio of advanced technologies.
myAirvo 2 air pathway
A uniquely designed air pathway thoroughly conditions the mix of air and oxygen to accurately deliver the patient’s set flow rate.
AirSpiral™ Tube
The two-spiral design produces up to 93% less condensate*, maximizing humidity levels of the breathing gas.
*When compared with Airvo tube 900PT501 in internal F&P testing
 | Set up with the Reusable Chamber Engineered to last up to two years and dishwasher safe. A. myAirvo 2 device B. Reusable Chamber C. Compact Stand D. AirSpiral Tube E. Optiflow interfaces for adult and peadiatric applications, including nasal cannula, tracheostomy and mask adapter options |
 | Set up with the Auto-fill Chamber Designed for use with the Water Bag for longer therapy sessions. A. myAirvo 2 device B. Auto-fill Chamber C. Water Bag D. Compact Stand E. AirSpiral Tube F. Optiflow interfaces for adult and peadiatric applications, including nasal cannula, tracheostomy and mask adapter options |
F&P, myAirvo, Airvo, AirSpiral and Optiflow are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see www.fphcare.com/ip